GW Pharma CEO on new cannabis-derived drug
GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.
Aurora Cannabis CEO discusses outlook of cannabis industry
Virginia is the latest state to approve adult-use marijuana legalization following New Jersey. Aurora Cannabis CEO Miguel Martin says he sees booming opportunity in the cannabis industry as more states…
Cronos CEO on nicotine vaping versus cannabis vaping
Cronos CEO Mike Gorenstein tells Jim Cramer what his company is doing different to enter the cannabis vaping space, particularly in the Canadian market.
Trulieve CEO Kim Rivers on Q4 earnings and cannabis adult use ballot in the U.S.
Kim Rivers, Trulieve CEO, founder, and chairwoman, joins ‘Fast Money’ to talk quarterly results, cannabis on the ballot, consumer trends and more.
Aurora Cannabis CEO Terry Booth to step down: RTRS
Aurora Cannabis CEO Terry Booth is reportedly stepping down. CNBC’s Seema Mody has the details.
Aurora Cannabis CEO Miguel Martin on new Amazon marijuana policy
Aurora Cannabis CEO Miguel Martin joins ‘Closing Bell’ to discuss Amazon’s new marijuana policy, adding that it’s important for the mainstreaming of cannabis. Subscribe to CNBC PRO for access to…
New Tilray CEO discusses building a global cannabis brand
Tilray shareholders voted to approve the merger with Aphria. New Tilray CEO Irwin Simon joins ‘Closing Bell’ to discuss the outlook of the cannabis brand. For access to live and…
Tilray CEO on Canada legalization, growth and the cannabis industry
Tilray CEO Brendan Kennedy sits down with CNBC’s ‘Squawk on the Street’ team to discuss the future of his company and the cannabis industry after Canada legalized recreational marijuana on…
Green Thumb CEO on what’s next for the cannabis industry
Ben Kovler, Green Thumb Industries CEO, on his company’s earnings and potential cannabis regulations from the government. With CNBC’s Courtney Reagan and the Fast Money traders, Guy Adami, Karen Finerman,…
Tilray CEO says the Canadian cannabis business needs a leader
Irwin Simon, Tilray CEO, joins ‘Closing Bell: Overtime’ to discuss the company’s M&A strategy, earnings and Canada’s cannabis business and regulation. For access to live and exclusive video from CNBC…